Opendata, web and dolomites

MImETIC INDiRECT SIGNED

MIcrovascularizED Tumour-on-chip for Cellular ImagiNg of Drug Response and Cell moTility

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MImETIC INDiRECT project word cloud

Explore the words cloud of the MImETIC INDiRECT project. It provides you a very rough idea of what is the project "MImETIC INDiRECT" about.

market    collagen    collaborations    cherry    manner    free    chips    components    reproducible    collagenous    toxicology    risks    types    temperature    academia    collaborative    plates    microvascularized    sectors    adoption    multidisciplinary    optional    microfluidic    scientific    marketing    sensor    medicine    cell    diverse    disseminated    direct    unconventional    standardization    drug    standardized    worldwide    indirect    dual    consist    create    discovery    platforms    academic    compatible    strategies    optimized    lines    skills    envision    mitigation    biomimetic    versatile    3d    promotes    live    complementary    personalized    chip    model    aforementioned    designed    dictated    migration    sub    industry    compact    standardised    mimetic    accessible    animal    disruptive    commercial    solutions    techniques    confocal    biology    tissue    cellular    cubix    controller    o2    cancer    appropriate    chamber    lanes    mentioned    toolkit    microscopy    culture    flow    biotech    integration    platform    formulations    organ    24    imaging    acquisition    clinical    cancerous    single   

Project "MImETIC INDiRECT" data sheet

The following table provides information about the project.

Coordinator
CHERRY BIOTECH 

Organization address
address: 6 RUE GURVAND
city: RENNES
postcode: 35000
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 196˙707 €
 EC max contribution 196˙707 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2018
 Funding Scheme MSCA-IF-EF-SE
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2021-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CHERRY BIOTECH FR (RENNES) coordinator 196˙707.00

Map

 Project objective

MImETIC INDiRECT aims to develop a standardised, accessible, versatile organ-on-chip toolkit for cancer biology and drug discovery research, compatible with microscopy-based (live imaging and confocal) techniques. The project is expected to facilitate academia and industry adoption of microfluidic 3D cell culture systems for comparable and reproducible results in a complex biomimetic animal free model for cancer drug discovery, toxicology, advanced (pre)clinical as well as personalized medicine. The toolkit components will consist of an integrated temperature controller dual-chamber chip, the Cherry Biotech CubiX system and growth factor optimized collagenous solutions for each chip chamber. The dual chamber chip, with cellular migration lanes, will have two tailored collagen-based formulations, designed per chamber. The CubiX platform is a compact flow and temperature controller, allowing optional sensor (e.g. O2) integration, compatible with single chips or 24-well plates. The cancer(s) sub-types to be used toolkit standardization will be dictated by market needs, where commercial cell lines (cancerous and non-cancerous) will be used to create the microvascularized complex tissue model. Potential project risks have been identified with appropriate mitigation strategies, where the project promotes adoption of standardized, cost-effective and versatile cancer organ-on-chip platforms in the market, rather than disruptive academic findings. Access of the aforementioned system to a worldwide growth market will fully exploit the project results, disseminated by direct and indirect marketing and scientific approaches. Project implementation will be an academic-industry collaborative and multidisciplinary manner providing the acquisition of diverse and unconventional complementary skills, leading to an understanding of both sectors requirements. We envision the above-mentioned to facilitate future academic and industry collaborations.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MIMETIC INDIRECT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MIMETIC INDIRECT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

LiquidEff (2019)

LiquidEff: Algebraic Foundations for Liquid Effects

Read More  

Cata-rotors (2019)

Visualising age- and cataract-related changed within cell membranes of human eye lens using molecular rotors

Read More  

DEAP (2019)

Development of Epithelium Apical Polarity: Does the mechanical cell-cell adhesions play a role?

Read More